Nitroglycerin tablet indications and usage: Difference between revisions

Jump to navigation Jump to search
Pratik Bahekar (talk | contribs)
No edit summary
Pratik Bahekar (talk | contribs)
No edit summary
Line 6: Line 6:
==Indications and Usage==
==Indications and Usage==


 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = NITROSTAT (NITROGLYCERIN) TABLET [PARKE-DAVIS DIV OF PFIZER INC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=79ba021e-183c-4b4d-822e-4ff5ef54ca61 | publisher =  | date =  | accessdate = 31 January 2014 }}</ref>
 


==References==
==References==

Revision as of 17:38, 31 January 2014

Nitroglycerin
NITROSTAT® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
MINITRAN® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]


Indications and Usage

[1]

References

  1. "NITROSTAT (NITROGLYCERIN) TABLET [PARKE-DAVIS DIV OF PFIZER INC]". Retrieved 31 January 2014.